Does Novartis AG (NVS) Pay a Dividend? (2026)

Yes. Novartis AG pays a dividend yielding roughly 3.04% as of July 2026, paid once a year. The most recent payment on record was $4.77 per share with an ex-dividend date of March 11, 2026. That works out to a forward annual rate of about $4.74 per share. Yields move with the share price, so verify the current figure with your broker or NVS's investor relations page before relying on it.

About 3.04% as of July 2026. On a $10,000 position that is roughly $304 of dividend income a year before tax. For context, the S&P 500 yields around 1.2%, so NVS yields meaningfully more than the broad market. A higher yield is not automatically better: it can reflect a falling share price as easily as a generous payout, so it is worth checking why the number is what it is.

Novartis AG pays once a year. The most recent payment on record had an ex-dividend date of March 11, 2026. To receive a given payment you have to own the shares before the ex-dividend date, not on the pay date. Confirm upcoming dates on NVS's investor relations page, because boards can change both the amount and the timing.

The ex-dividend date recorded in our July 2026 data pull is March 11, 2026. The ex-dividend date is the cutoff: buy on or after it and the seller keeps that payment, not you. Buying just before the ex-date to capture the dividend does not create free money, because the share price typically drops by roughly the dividend amount when the stock goes ex. Check NVS's investor relations page for the next confirmed date.

$4.77 per share in the most recent payment (ex-date March 11, 2026), which annualizes to about $4.74 per share. The equivalent payment a year earlier was $3.99. That is a change of 19.5% year over year.

Yes. The latest payment of $4.77 per share is above the $3.99 paid in the same slot a year earlier, an increase of about 19.5%. One raise is not a policy, though: check the multi-year record on NVS's investor relations page, since a long streak of increases is what dividend-growth investors actually look for.

Novartis AG paid out about 72% of its earnings as dividends, so the dividend takes a large share of earnings. It is covered, but future increases depend more on earnings growth than on stretching the payout further, and a bad year leaves less cushion. Nobody can guarantee a dividend: boards cut them, and a high yield is sometimes the market pricing in exactly that. Walnut is not an investment adviser and this is not a recommendation.

At a yield of about 3.04%, roughly $304 a year before tax, spread across 1 payment. That is a snapshot, not a promise: the amount changes when the company changes its payout, and your yield on cost is fixed at the price you paid, not at today's price.

Dividends from US common stock are usually qualified, meaning they are taxed at the lower long-term capital-gains rates, provided you held the shares for more than 60 days in the 121-day window around the ex-dividend date. Distributions from REITs, BDCs, and some pass-through structures are generally taxed as ordinary income instead. In an IRA or Roth the question does not arise. See our guide to how dividends are taxed. This is not tax advice.

Most brokers offer automatic reinvestment (a DRIP) that puts each NVS payment straight back into more shares, often fractional ones. Reinvesting compounds the position and is the standard choice when you do not need the cash yet. Taking the cash makes sense when you are spending the income or want to direct it elsewhere. Either way the dividend is taxable in a taxable account in the year it is paid, even if you never see the money.

Yes. Novartis pays a dividend and has a long history of annual increases, which is part of its appeal to income investors. Unlike most US companies that pay quarterly, Novartis pays once a year, and for ADR holders the amount is affected by currency and by Swiss dividend withholding tax. Always check the latest declared dividend, ex-date, and yield before assuming any payout.